Internal Server Error

SynThera Biomedical - About the company

SynThera Biomedical is a seed company based in Pune (India), founded in 2015 by Nilay Lakhkar. It operates as a Manufacturer of glass-based biomaterials. SynThera Biomedical has raised $406K in funding from IKP Knowledge Park and Venture Center, with a current valuation of $*****. The company has 130 active competitors, including 45 funded and 24 that have exited. Its top competitors include companies like Ossio, RevBio and Theradaptive.

Company Details

Manufacturer of glass-based biomaterials. It develops, manufactures, and commercializes bio-active and other specialty glass and ceramic products for healthcare and other sectors. The glass-based bio-materials are used in various biomedical applications such as dental, maxillo-facial, and orthopedic bone substitutes, bone tissue engineering scaffolds, and antimicrobial ion delivery vehicles. These bio-active materials are either silicate or phosphate-based.
Email ID
*****@synthera.in
Registered Address
F. No. E/202, S. No. 5, HN 2/2, Baner Pune Felicita, Behind RMZ, BANER, Pune, PUNE, Maharashtra, India, 411045
Key Metrics
Founded Year
2015
Location
Pune, India
Stage
Seed
Total Funding
$406K in 3 rounds
Latest Funding Round
Post Money Valuation
$***** as on Apr 25, 2018
Ranked
Annual Revenue
0 - ₹10 Cr as on Mar 31, 2025
Employee Count
9 as on Jul 31, 2026
Similar Companies
Sign up to download SynThera Biomedical's company profile

SynThera Biomedical's funding and investors

SynThera Biomedical has raised a total funding of $406K over 3 rounds. Its first funding round was on Apr 25, 2018. Its latest funding round was a Seed round on Nov 10, 2021 for $*****. 1 investor participated in its latest round. SynThera Biomedical has 11 institutional investors and 24 angel investors.

Here is the list of recent funding rounds of SynThera Biomedical:
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Nov 10, 2021
4044123
Seed
4198402
8288851
9849370
9075616
2018
3406
Seed
8858
1791
9311
Apr 25, 2018
2467941
Seed
5328692
5988457
lockAccess funding benchmarks and valuations. Sign up today!

SynThera Biomedical's founders and board of directors

Founder? Claim Profile
The founders of SynThera Biomedical is Nilay Lakhkar. Nilay Lakhkar is the CEO of SynThera Biomedical.
Here are the details of SynThera Biomedical's key team members:

SynThera Biomedical's Board of Directors

SynThera Biomedical's board has 5 active members. Natasha Kothari, Nilay Lakhkar, Jayant Anand Lakhkar and Jayant Lakhkar are part of team and Mugdha Potnis-Lele is independent board member.
Here is the list of SynThera Biomedical's board of directors:
Name
Type
Representing
Status
Duration
Team
-
Current
11y 0m
Team
-
Current
11y 0m
Team
-
Current
11y 0m
dauwbib
Investor
juuucbf
Past
9y 2m
Independent board member
-
Current
10y 9m

SynThera Biomedical's employee count trend

SynThera Biomedical has 9 employees as of Jul 26. Here is SynThera Biomedical's employee count trend over the years:
Employee count trend for SynThera Biomedical
lockUncover SynThera Biomedical's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

SynThera Biomedical's Competitors and alternates

Top competitors of SynThera Biomedical include Ossio, RevBio and Theradaptive. Here is the list of Top 10 competitors of SynThera Biomedical, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Ossio
Ossio
2014, Caesarea (Israel), Series C
Bone regeneration biocomposite
$89M
64/100
2nd
Logo for RevBio
RevBio
2014, Lowell (United States), Series B
Developer of synthetic adhesive used for bone/dental repair
$27.5M
63/100
3rd
Logo for Theradaptive
Theradaptive
2004, Boston (United States), Series A
Developer of protein engineering technology creating targeted therapeutics for tissue repair
$50M
61/100
4th
Logo for MiMedx Group
MiMedx Group
1985, Marietta (United States), Public
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics
-
61/100
5th
Logo for Cerapedics
Cerapedics
1996, Westminster (United States), Series D
Developer of Osteobiologic products
$88.5M
58/100
6th
Logo for Serigen
Serigen
2015, Pune (India), Seed
Develops silk protein-based biomedical products for tissue regeneration and healing
$3.63M
53/100
7th
Logo for Tissue Regenix
Tissue Regenix
2006, Swillington (United Kingdom), Public
Developer of regenerative medical devices by using cell technology
-
53/100
8th
Logo for Biocomposites
Biocomposites
1999, Keele (United Kingdom), Early Stage
Developer of synthetic calcium composite products for bone repair and regeneration
$1.8M
53/100
9th
Logo for CartiHeal
CartiHeal
2009, Kfar Saba (Israel), Acquired
Provider of implant for bone and cartilage regeneration
$65.8M
51/100
10th
Logo for Epibone
Epibone
2013, Brooklyn (United States), Series B
Developer of patient‑specific bone and cartilage grafts
$48.6M
51/100
16th
Logo for SynThera Biomedical
SynThera Biomedical
2015, Pune (India), Seed
Manufacturer of glass-based biomaterials
$406K
41/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on SynThera Biomedical's competitors? Click here to see the top ones

SynThera Biomedical's Latest cap tables and shareholding

Founders (largest shareholder) own 65.77%, Funds own 7.77%, Enterprises own 1.10% and Angels own 17.59%. The net worth of SynThera Biomedical's founders is INR 5.99Cr as of Apr 25, 2018.
Shareholders Name
Post Round Holding %
Net worth
Cumulative Investment
Realised Returns
Unrealised Returns
Return Multiple
Founder
65.77%
5.99Cr
2496800
6372782
8634260
3742969
4733869
6648790
2098798
3668933
8720436
1905648
Fund
7.77%
70.9L
5049549
9735611
6648321
2885370
743225
799189
773216
542458
466307
448227
Enterprise
1.10%
10.1L
1
2
7
6
Angel
17.59%
1.61Cr
2120304
5917432
8908548
4720355
ESOP Pool
7.69%
70L
3396972
4778727
2765795
7245243
Total
99.92%
9.11Cr
6600029
4333792
7096007
1162949
lockTo unlock detailed Cap Table of SynThera Biomedical Sign up today!
Notes: The column Net Worth represents the net worth of investments made by that entity, as per the latest cap table.
Disclaimer

SynThera Biomedical's Investments and acquisitions

SynThera Biomedical has made no investments or acquisitions yet.

Reports related to SynThera Biomedical

Here is the latest report on SynThera Biomedical's geography:

News related to SynThera Biomedical

lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about SynThera Biomedical

Explore our recently published companies
  • Elm Biosciences - New York City based, 2024 founded, Seed company
  • Whoranks - Wien based, 2024 founded, Funding Raised company
  • Hedlum - New York City based, 2023 founded, Funding Raised company
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford